西维斯健康CVS Health（CVS）2025年第二季度业绩报告「NYSE」（英文版）（24页）.pdf

1、 Exhibit 99.1 CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCEFinancial HighlightsSecond quarter total revenues increased to$98.9 billion,up 8.4%compared to prior yearSecond quarter GAAP diluted EPS of$0.80 and Adjusted EPS of$1.81Generated year-to-date

2、cash flow from operations of$6.5 billionOperational HighlightsAetna delivers distinctive advances in care navigationCVS Pharmacy agreed to acquire certain prescription files and store locations from Rite AidCVS Caremark demonstrates market-leading innovation in strong renewal and sales season2025 Fu

3、ll-Year GuidanceRevised GAAP diluted EPS guidance range to$3.84 to$3.94 from$4.23 to$4.43Raised Adjusted EPS guidance range to$6.30 to$6.40 from$6.00 to$6.20Raised cash flow from operations guidance to at least$7.5 billion from approximately$7.0 billionCEO Commentary“What people want most a connecte

4、d,simpler health care experience is what CVS Health uniquely provides.For the 185 million people we serve,we deliver better access,greater affordability and aligned advocacy.Our strong performance demonstrates the continued focus we have on operational and financial improvement across our businesses

5、,led by a significant and durable recovery at Aetna,strong retention at CVS Caremark and growth and momentum at CVS Pharmacy.”David Joyner,CVS Health President and CEO WOONSOCKET,RHODE ISLAND,July 31,2025-CVS Health Corporation(NYSE:CVS)today announced operating results for the three months ended Ju

6、ne 30,2025.Financial Results SummaryThree Months EndedJune 30,In millions,except per share amounts20252024ChangeTotal revenues$98,915$91,234$7,681 Operating income 2,381 3,045 (664)Adjusted operating income(1)3,808 3,744 64 Diluted earnings per share$0.80$1.41$(0.61)Adjusted EPS(2)$1.81$1.83$(0.02)S